Panbela Therapeutics
Dr. Elizabeth Bruckheimer joined Panbela as Vice President and Chief Scientific Officer in June 2022. Her professional career spans 20 years in oncology research, the biotech/pharmaceutical industry, and contract research organizations. In those endeavors, she led cross-functional preclinical/translational drug development programs, laboratory/organizational operations, regulatory affairs, project management, and business development activities.
This person is not in any offices
Panbela Therapeutics
Panbela Therapeutics is a biopharmaceutical company that develops and distributes therapeutics for the treatment of pancreatic cancer.